Table 2.
Case | Indication for genetic testing | NIPT | Diagnostic genetic testing | Outcome | Classification of aberration | |||
---|---|---|---|---|---|---|---|---|
Timing | Result | Timing | Test | Result | ||||
3 | IUGR | 15 weeks | T16 | 16 weeks | QF‐PCR, karyotype, FISH | 46,XX 46,XX D16Z3 × 2 | Preterm LB with no congenital anomaly, extreme dysmaturity, perinatal death | Causative |
Postnatal | Microarray | arr 16p13.3p13.2(89,561‐8,914,906) × 2 hmz = UPD (16)mat* | ||||||
4 | NT 4.7 mm | 13 weeks | Gain of 8p† | 16 weeks | Karyotype, microarray |
46,XX,del(8)(p23.3p23.1), dup(8)(p23.1p11.21) arr 8p23.3p23.1(158,049‐6,976,182) × 1 dn, 6.8 Mb, 8p23.1p11.21(11,936,001‐40,905,009) × 3 dn, 29 Mb |
TOP | Causative |
5 | IUGR | 21 weeks | Gain of 21q‡ | 22 weeks | Maternal microarray | arr 21q22.11(33,522,970‐33,889,304) × 3, ∼370 kb (6 genes) | LB with no congenital anomaly | Incidental |
6 | IUGR | 21 weeks | Gain of 18p§ | NP | LB, two small VSDs (resolved spontaneously), mild dysmorphisms |
Maternal uniparental disomy of chromosome 16, most likely due to ‘trisomy 16 rescue’; placental material not available for testing.
Software analysis showed 30‐Mb gain of 8p; visual inspection of plots showed also a (smaller) 8p terminal loss.
Software analysis showed 10‐Mb gain of 21q; visual inspection of plots showed relatively high region‐specific Z‐score, therefore, maternal origin was suspected; consultation with clinical geneticist revealed no maternal dysmorphic features or physical or neurodevelopmental anomaly; copy number variant therefore classified as most probably benign.
Software analysis showed 15‐Mb gain of 18p.
FISH, fluorescent in‐situ hybridization; IUGR, intrauterine growth restriction; kb, kilobases; LB, live birth; Mb, megabases; NP, not performed; NT, nuchal translucency thickness; QF‐PCR, quantitative fluorescent polymerase chain reaction; T16, trisomy 16; TOP, termination of pregnancy; VSD, ventricular septal defect.